Involvement of a Ca 2+ channel gene in familial hemiplegic migraine and migraine with and without aura

Headache

Volumn 37, Issue 8, 1997, Pages 479-485

  Ophoff, Roel A ^a,b,c   Terwindt, Gisela M ^a,c   Vergouwe, Monique N ^a,b,c   Frants, Rune R ^a,b   Ferrari, Michel D ^a,c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Netherlands University   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CACNA 1A; Calcium channel; Chromosome 19p13; Genetics; Migraine

Indexed keywords

ACETAZOLAMIDE; CALCIUM CHANNEL; CALCIUM ION;

ARTICLE; ATAXIA; CALCIUM TRANSPORT; CHROMOSOME 19P; CLINICAL ARTICLE; DNA SEQUENCE; GENE DISRUPTION; GENETIC LINKAGE; HAPLOTYPE; HEMIPLEGIA; HUMAN; HUMAN CELL; MIGRAINE; PRIORITY JOURNAL; ALLELE; ANIMAL; CHROMOSOME 19; CLASSIFICATION; GENETICS; METABOLISM; MUTATION; REVIEW;

ALLELES; ANIMALS; CALCIUM CHANNELS; CHROMOSOMES, HUMAN, PAIR 19; HEMIPLEGIA; HUMANS; MIGRAINE DISORDERS; MUTATION;

EID: 0031228095     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1997.3708479.x     Document Type: Article

References (43)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):19-28.
2. Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995;24:612-618.
3. Haan J, Terwindt GM, Ferrari MD. Genetics of migraine. In: Mathew NT, ed. Advances in Headache. Philadelphia: WB Saunders Co; 1997.
4. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995;311:541-544.
5. Terwindt GM, Ophoff RA, Haan J, Frants RR, Ferrari MD. Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19. Cephalalgia. 1996; 16:153-155.
6. Haan J, Terwindt GM, Bos PL, Ophoff RA, Frants RR, Ferrari MD. Familial hemiplegic migraine in The Netherlands. Clin Neurol Neurosurg. 1994;96:244-249.
7. Joutel A, Bousser MG, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993;5:40-45.
8. Ophoff RA, van Eijk R, Sandkuijl LA, et al. Genetic heterogeneity of familial hemiplegic migraine. Genomics. 1994;22:21-26.
9. Joutel A, Ducros A, Vahedi K, et al. Genetic heterogeneity of familial hemiplegic migraine. Am J Hum Genet. 1994;55:1166-1172.
10. Ophoff RA, Terwindt GM, Vergouwe MN, et al. A 3 Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2; exclusion of PRKCSH as a candidate gene. Eur J Hum Genet. 1996. In press.
11. May A, Ophoff RA, Terwindt GM, et al. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet. 1995;96:604-608.
12. von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE. Mapping the gene for acetazolamide responsive hereditary paroxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet. 1995;4:279-284.
13. Kramer PL, Yue Q, Gancher ST, et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am J Hum Genet. 1995;57:182-185.
14. Teh BT, Silburn P, Lindblad K, et al. Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13. Am J Hum Genet. 1995;56:1443-1449.
15. Ptacek LJ, George AL Jr, Griggs RC, et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell. 1991;67:1021-1027.
16. Ptacek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell. 1994;77:863-868.
17. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/ myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994;8:136-140.
18. Jurkatt-Rott K, Lehmann-Horn F, Elbaz A, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet. 1994;3:1415-1419.
19. Griggs RC, Nutt JG. Episodic ataxias as channelopathies. Ann Neurol. 1995;37:285-287.
20. 2+ channel gene CACNL1A4. Cell. 1996;87:543-552.
21. 2+ channel subunits. Genomics. 1995;30:605-609.
22. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874-879.
23. Oefner PJ, Underbill PA. Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC). Am J Hum Genet. 1995;57(suppl):A266. Abstract.
24. Suarez BK, Hodge SE. A simple method to detect linkage for rare recessive diseases: an application to juvenile diabetes. Clin Genet. 1979; 15:126-136.
25. Campbell KP, Leung AT, Sharp AH. The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel. Trends Neurosci. 1988;11:425-430.
26. Guy HR, Durell SR. Three-dimensional models of ion channel proteins. In: Narahashi T, ed. Ion Channels. IV. New York: Plenum Press; 1996.
27. Cannon SC. Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends Neurosci. 1996;19:3-10.
28. Hudson AJ, Ebers GC, Bulman DE. The skeletal muscle sodium and chloride channel diseases. Brain. 1995;118:547-563.
29. De Waard M, Gurnett CA, Campbell KP. Structural and functional diversity of voltage-activated calcium channels. In: Narahashi T, ed. Ion Channels. IV. New York: Plenum Press; 1996.
30. Orr HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993;4:221-226.
31. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:971-983.
32. Zhuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat Genet. 1997;15:62-69.
33. Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 1993;13:151-165.
34. Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology. 1989;39:1239-1242.
35. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992;13:307-311.
36. Ferrari MD, Saxena PR. 5-HT, receptors in migraine pathophysiology and treatment. Eur J Neurol. 1995;2:5-21.
37. Codignola A, Tarroni P, Clementi F, et al. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. J Biol Chem. 1993;268:26240-26247.
38. Altura BM. Calcium antagonist properties of magnesium: implications for antimigraine actions. Magnesium. 1985;4:169-175.
39. Zhang A, Cheng TP, Altura BM. Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cell. Biochem Biophys Acta. 1992;1134:25-29.
40. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM. Low brain magnesium in migraine. Headache. 1989;29:416-419.
41. Peikert A, Wilimzig C, Kohne-Volland R. Prohylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16:257-263.
42. Lauritzen M. Pathophysiology of the migraine aura. Sci Med. 1996;3:32-41.
43. Fletcher CF, Lutz CM, O'Sullivan TN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell. 1996;87:607-617.